For More Information and To Stay Updated on The Latest Developments in The Artificial Intelligence MarketSize, Download FREE Sample Pages: ...

Although still in its infancy, this technology has already shown remarkable effectiveness in detecting and treating cancer, ...

Capricor Therapeutics is seeking FDA approval for CAP-1002, targeting heart function in Duchenne Muscular Dystrophy patients.

Capricor's lead asset, deramiocel, targets DMD-related cardiomyopathy and faces key FDA milestones. Find out why CAPR stock ...